@Praetorian2011 - ok its up. Let me know if there's anything else you want queried - and yes, you should def signup with Yahoo - the more people who can have good commentary on both boards, the better!7 seconds ago@Invest31415 @Left-e @otherperspective @Ariya @london @Longstock @ - Anyone but Tom...
Query from Praetorian2011 on HC to you all, around- Novartis's conflict of interest re Jakafi (Rux) and likely engagement of Lassman Law firm to object to Ryoncil. Was this effectively a horse's head on Itescu's pillow, to say "you partner with us, or else we continue to block" action, possibly.
So now, with the partnership - they'll no longer block the treatment - or is it still a play by them, to take MESO off the table (I think no - they'll now push the treatments approval btw).
Overall, where do you think Ryoncil sits, vis-a-vis Rux - is it complementary, for use in more severe cases in the adult pop, and for children? Or is it more likely a replacement (I think complementary btw, due to relative cost - at least initially - once proper total cost of treatment metrics are bought in, it may well stack up as the overall cheaper option in a lot of cases, not just the more effective one).
https://hotcopper.com.au/threads/msb-to-dispute-fda-finding-in-type-a-meeting.5663639/page-732?post_id=50210976
Thanks all, any and all responses appreciated.
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-759
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $4.738M | 4.022M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 96659 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 116483 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 81319 | 1.160 |
21 | 92137 | 1.155 |
14 | 105511 | 1.150 |
14 | 206116 | 1.145 |
9 | 199738 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 103580 | 12 |
1.170 | 111075 | 18 |
1.175 | 51315 | 8 |
1.180 | 77792 | 10 |
1.185 | 36343 | 4 |
Last trade - 14.57pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online